Scotiabank raised the firm’s price target on Omega Healthcare (OHI) to $42 from $39 and keeps a Sector Perform rating on the shares. The firm is updating its price targets on stocks in the U.S. Real Estate & REITs sector under its coverage following Q2 results, the analyst tells investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OHI:
- MedaSync announces strategic investment from Omega Healthcare
- Omega Healthcare Investors Reports Strong Q2 2025 Results
- Omega Healthcare Investors’ Earnings Call Highlights Robust Growth
- Omega Healthcare’s Strong Q2 Performance and Strategic Moves Justify Buy Rating
- Omega Healthcare reports Q2 adjusted FFO 77c, consensus 76c